Literature DB >> 25352253

Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study.

Cyril C Curtain1, Nigel M Kirby, Haydyn D T Mertens, Kevin J Barnham, Robert B Knott, Colin L Masters, Roberto Cappai, Agata Rekas, Vijaya B Kenche, Timothy Ryan.   

Abstract

The 140 residue intrinsically disordered protein α-synuclein (α-syn) self-associates to form fibrils that are the major constituent of the Lewy body intracellular protein inclusions, and neurotoxic oligomers. Both of these macromolecular structures are associated with a number of neurodegenerative diseases, including Parkinson's disease and dementia with Lewy bodies. Using ensemble optimisation modelling (EOM) and small angle X-ray scattering (SAXS) on a size-exclusion column equipped beamline, we studied how the distribution of structural conformers in α-syn may be influenced by the presence of the familial early-onset mutations A30P, E45K and A53T, by substituting the four methionine residues with alanines and by reaction with copper (Cu2+) or an anti-fibril organic platinum (Pt) complex. We found that the WT had two major conformer groups, representing ensembles of compact and extended structures. The population of the extended group was increased in the more rapidly fibril-forming E45K and A53T mutants, while the compact group was enlarged in the oligomer-forming A30P mutant. Addition of Cu2+ resulted in the formation of an ensemble of compact conformers, while the anti-fibril agent and alanine substitution substantially reduced the population of extended conformers. Since our observations with the mutants suggest that fibrils may be drawn from the extended conformer ensemble, we propose that the compact and extended ensembles represent the beginning of oligomer and fibril formation pathways respectively, both of which have been reported to lead to a toxic gain of function. Manipulating these pathways and monitoring the results by EOM and SAXS may be useful in the development of anti-Parkinson's disease therapies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25352253     DOI: 10.1039/c4mb00356j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  12 in total

1.  Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.

Authors:  Igor F Tsigelny; Yuriy Sharikov; Valentina L Kouznetsova; Jerry P Greenberg; Wolf Wrasidlo; Cassia Overk; Tania Gonzalez; Margarita Trejo; Brian Spencer; Kori Kosberg; Eliezer Masliah
Journal:  ACS Chem Neurosci       Date:  2015-01-21       Impact factor: 4.418

Review 2.  Are Charge-State Distributions a Reliable Tool Describing Molecular Ensembles of Intrinsically Disordered Proteins by Native MS?

Authors:  Antonino Natalello; Carlo Santambrogio; Rita Grandori
Journal:  J Am Soc Mass Spectrom       Date:  2016-10-11       Impact factor: 3.109

Review 3.  Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.

Authors:  Orkid Coskuner-Weber; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

4.  Familial Mutations May Switch Conformational Preferences in α-Synuclein Fibrils.

Authors:  Liang Xu; Buyong Ma; Ruth Nussinov; Damien Thompson
Journal:  ACS Chem Neurosci       Date:  2017-01-27       Impact factor: 4.418

5.  Structures of the troponin core domain containing the cardiomyopathy-causing mutants studied by small-angle X-ray scattering.

Authors:  Tatsuhito Matsuo; Soichi Takeda; Toshiro Oda; Satoru Fujiwara
Journal:  Biophys Physicobiol       Date:  2015-12-22

Review 6.  Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.

Authors:  Mattia Toni; Maria L Massimino; Agnese De Mario; Elisa Angiulli; Enzo Spisni
Journal:  Front Neurosci       Date:  2017-01-19       Impact factor: 4.677

Review 7.  The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy.

Authors:  Francesca Longhena; Gaia Faustini; Cristina Missale; Marina Pizzi; PierFranco Spano; Arianna Bellucci
Journal:  Neural Plast       Date:  2017-01-03       Impact factor: 3.599

8.  Formation of covalent di-tyrosine dimers in recombinant α-synuclein.

Authors:  A van Maarschalkerweerd; M N Pedersen; H Peterson; M Nilsson; Ttt Nguyen; T Skamris; K Rand; V Vetri; A E Langkilde; B Vestergaard
Journal:  Intrinsically Disord Proteins       Date:  2015-10-19

9.  Comprehensive Structural and Thermodynamic Analysis of Prefibrillar WT α-Synuclein and Its G51D, E46K, and A53T Mutants by a Combination of Small-Angle X-ray Scattering and Variational Bayesian Weighting.

Authors:  Paolo Moretti; Paolo Mariani; Maria Grazia Ortore; Nicoletta Plotegher; Luigi Bubacco; Mariano Beltramini; Francesco Spinozzi
Journal:  J Chem Inf Model       Date:  2020-09-17       Impact factor: 4.956

10.  A small-angle X-ray scattering study of alpha-synuclein from human red blood cells.

Authors:  Katsuya Araki; Naoto Yagi; Rie Nakatani; Hiroshi Sekiguchi; Masatomo So; Hisashi Yagi; Noboru Ohta; Yoshitaka Nagai; Yuji Goto; Hideki Mochizuki
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.